Podcast #33: Foreign-Sponsored Clinical Trials Under China's Human Genetic Resources Regime – Tina Wu, Haiwen & Partners

China's HGR regime still delays foreign-sponsored clinical research despite recent streamlining of review process

2 minute readMay 14, 2021 at 12:25 AM

Vincent Chow

Podcast #33: Foreign-Sponsored Clinical Trials Under China's Human Genetic Resources Regime – Tina Wu, Haiwen & Partners

Human genetic resources such as organs, cells, and tissue are crucial to the clinical trials that pharmaceutical multinationals conduct in order to get their products registered for use in China,

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)